During the past decade, Nzoz Bif - Med conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nzoz Bif - Med" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eupraxia Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nzoz Bif - Med" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "NBCD A/S" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "Nordic Bioscience Clinical Development (NBCD)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Nzoz Bif - Med" are "Rheumatoid Arthritis" (5 trials), "Systemic Lupus Erythematosus" (3 trials), "Arthritis" (2 trials), "Arthritis, Psoriatic" (2 trials) and "Joint Diseases" (2 trials). Many other conditions were trialed in "Nzoz Bif - Med" in a lesser frequency.

Most popular intervention types in "Nzoz Bif - Med" are "Drug" (14 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Guselkumab" (2 trials), "Adalimumab with methotrexate" (1 trials), "BMS-986165" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nzoz Bif - Med" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Nzoz Bif - Med". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nzoz Bif - Med, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nzoz Bif - Med, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".